KENGREAL 50 mg/1
cangrelor · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Chiesi USA, Inc.
No Recall History
Plain English
KENGREAL is a injection, powder, lyophilized, for solution containing cangrelor at 50 mg/1, taken intravenous. Manufactured by Chiesi USA, Inc..
Key Facts
- Brand Name
- KENGREAL
- Generic Name
- cangrelor
- NDC Code (Product)
10122-620- Manufacturer
- Chiesi USA, Inc.
- Strength
- 50 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA204958
- Drug Class
- P2Y12 Platelet Inhibitor [EPC]
- Marketing Start
- 07/08/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is KENGREAL used for?
KENGREAL contains cangrelor. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is KENGREAL a controlled substance?
KENGREAL is not classified as a controlled substance by the DEA.
What is the generic name for KENGREAL?
The generic name for KENGREAL is cangrelor. There are 1 other brand versions of cangrelor.
What is the NDC code for KENGREAL 50 mg/1?
The NDC (National Drug Code) for KENGREAL 50 mg/1 is 10122-620, listed by Chiesi USA, Inc..